secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2022-04-15T23:59:59+00:00
Accession:  0001575872-22-000277
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital Acquisition Corp. completes $82.5M IPO and $5.1M private placement
--------------------------------------------------------------------------------

- IPO of 8,250,000 units at $10.00/unit raised $82.5M gross; private placement of 510,000 units to sponsor raised $5.1M.
- Total $84.15M deposited into trust account for benefit of public shareholders; redemption value set at $10.20/share.
- Company has 12 months (extendable to 18) to complete a business combination or will liquidate.
- Each unit consists of one Class A share and one warrant exercisable at $11.50 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000157587222000277/0001575872-22-000277-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000157587222000277/deca-20220411.htm
  HTML page:      https://secwatch.observer/filing/0001575872-22-000277

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer